Transition Metals in Organic Synthesis, Part 82. [1] First Total Synthesis of Methyl 6-Methoxycarbazole-3-carboxylate, Glycomaurrol, the Anti-TB Active Micromeline, and the Furo[2,3-c]carbazole Alkaloid Eustifoline-D

Abstract

The palladium(0)-catalyzed amination followed by palladium(II)-catalyzed oxidative cyclization of the resulting diaryl­amine provides a short route to a series of 6-oxygenated carbazole alkaloids: glycozoline, 3-formyl-6-methoxycarbazole, methyl 6-methoxycarbazole-3-carboxylate, glycozolinine (glycozolinol), glycomaurrol, micromeline, and eustifoline-D.

alkaloids - antibiotics - catalysis - nickel - palladium

References and Notes

1 Part 81: Krahl MP. Jäger A. Krause T. Knölker H.-J. Org. Biomol. Chem.  2006,  4:  3215 

2a Chakraborty DP. Roy S. In Progress in the Chemistry of Organic Natural Products   Vol. 57:  Herz W. Grisebach H. Kirby GW. Steglich W. Tamm C. Springer; Wien: 1991.  p.71 

2b Chakraborty DP. In The Alkaloids   Vol. 44:  Cordell GA. Academic Press; New York: 1993.  p.257 

3a Knölker H.-J. Reddy KR. Chem. Rev.  2002,  102:  4303 

3b Knölker H.-J. Top. Curr. Chem.  2005,  244:  115 

4a Pindur U. Chimia  1990,  44:  406 

4b Bergman J. Pelcman B. Pure Appl. Chem.  1990,  62:  1967 

4c Kawasaki T. Sakamoto M. J. Indian Chem. Soc.  1994,  71:  443 

4d Moody CJ. Synlett  1994,  681 

4e Hibino S. Sugino E. In Advances in Nitrogen Heterocycles   Vol. 1:  Moody CJ. JAI Press; Greenwich (CT): 1995.  p.205 

4f Kirsch GH. Curr. Org. Chem.  2001,  5:  507 

4g Lemster T. Pindur U. Recent Res. Dev. Org. Bioorg. Chem.  2002,  5:  99 

5 Kataeva O. Krahl MP. Knölker H.-J. Org. Biomol. Chem.  2005,  3:  3099 

6a Chakraborty DP. Das K. Das BP. Chowdhury BK. Trans. Bose Res. Inst.  1975,  38:  1 

6b Chowdhury DN. Basak SK. Das BP. Curr. Sci.  1978,  47:  490 

7a Chakraborty DP. Tetrahedron Lett.  1966,  661 

7b Chakraborty DP. Phytochemistry  1969,  8:  769 

8a Adesina SK. Olatunji OA. Bergenthal D. Reisch J. Pharmazie  1988,  43:  221 

8b Ito C. Thoyama Y. Omura M. Kajiura I. Furukawa H. Chem. Pharm. Bull.  1993,  41:  2096 

9 Chakravarty AK. Sarkar T. Masuda K. Shiojima K. Phytochemistry  1999,  50:  1263 

10 Rastogi K. Kapil RS. Popli SP. Phytochemistry  1980,  19:  945 

11 Li W.-S. McChesney JD. El-Feraly FS. Phytochemistry  1991,  30:  343 

12 Adesina SK. Olugbade TA. Akinwusi DD. Bergenthal D. Pharmazie  1997,  52:  720 

13a Mukherjee S. Mukherjee M. Ganguly SN. Phytochemistry  1983,  22:  1064 

13b Bhattacharyya P. Sarkar T. Chakraborty A. Chowdhury BK. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem.  1984,  23:  49 

14 Wu S.-L. Li W.-S. Chin. Pharm. J.  1999,  51:  227 

15 Kumar V. Reisch J. Wickramasinghe A. Aust. J. Chem.  1989,  42:  1375 

16 Ma C. Case RJ. Wang Y. Zhang H.-J. Tan GT. Hung NV. Cuong NM. Franzblau SG. Soejarto DD. Fong HHS. Pauli GF. Planta Med.  2005,  71:  261 

17 Ito C. Furukawa H. Chem. Pharm. Bull.  1990,  38:  1548 

18a Chakraborty DP. Das KC. Chowdhury BK. Sci. Cult.  1966,  32:  245 

18b Chakraborty DP. Das KC. Chowdhury BK. Chem. Ind.  1966,  1684 

18c Carruthers W. J. Chem. Soc., Chem. Commun.  1966,  272 

18d Bhattacharyya P. Mitra AR. Chakraborty DP. J. Indian Chem. Soc.  1976,  53:  321 

18e Bhattacharyya P. Jash SS. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem.  1986,  25:  1056 

18f Kudav DP. Kulkarni NN. Hosangadi BD. J. Chem. Res., Synop.  1994,  266 

19a Anwer F. Masaldan AS. Kapil RS. Popli SP. Indian J. Chem.  1973,  11:  1314 

19b Chowdhury BK. Saha C. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem.  1994,  33:  892 

20 Iwao M. Takehara H. Furukawa S. Watanabe M. Heterocycles  1993,  36:  1483 

21a Fröhner W. Krahl MP. Reddy KR. Knölker H.-J. Heterocycles  2004,  63:  2393 

21b Knölker H.-J. Reddy KR. In Selected Methods for Synthesis and Modification of Heterocycles - The Chemistry and Biological Activity of Natural Indole Systems   Part 1, Vol. 4:  Kartsev VG. ICSPF Press; Moscow: 2005.  p.166 

22a Hartwig JF. Angew. Chem. Int. Ed.  1998,  37:  2046 

22b Muci AR. Buchwald SL. Top. Curr. Chem.  2002,  219:  131 

23a Åkermark B. Eberson L. Jonsson E. Petersson E. J. Org. Chem.  1975,  40:  1365 

23b Miller RB. Moock T. Tetrahedron Lett.  1980,  21:  3319 

23c Furukawa H. Ito C. Yogo M. Wu T.-S. Chem. Pharm. Bull.  1986,  34:  2672 

23d Knölker H.-J. O’Sullivan N. Tetrahedron  1994,  50:  10893 

23e Knölker H.-J. Fröhner W. Reddy KR. Synthesis  2002,  557 

23f Knölker H.-J. Reddy KR. Heterocycles  2003,  60:  1049 

23g Knölker H.-J. Knöll J. Chem. Commun.  2003,  1170 

24 The preparation of compound 10 using a Pd(0)-catalyzed amination has been reported previously, albeit in lower yield (77%): Urgaonkar S. Xu J.-H. Verkade JG. J. Org. Chem.  2003,  68:  8416 

25 Corey EJ. Gilman NW. Ganem BE. J. Am. Chem. Soc.  1968,  90:  5616 

26a Wilke G. Bogdanovic B. Hardt P. Heimbach P. Keim W. Kröner M. Oberkirch W. Tanaka K. Steinrücke E. Walter D. Zimmermann H. Angew. Chem., Int. Ed. Engl.  1966,  5:  151 

26b Corey EJ. Semmelhack MF. J. Am. Chem. Soc.  1967,  89:  2755 

26c Plieninger H. Sirowej H. Chem. Ber.  1971,  104:  2027 

26d Inoue S. Yamaguchi R. Saito K. Sato K. Bull. Chem. Soc. Jpn.  1974,  47:  3098 

26e Billington DC. Chem. Soc. Rev.  1985,  14:  93 

27

Pure glycomaurrol (5) was obtained by preparative HPLC on a Vydac C8 50 mm column (gradient elution with 50 mL/min MeCN-H₂O, 30-60% MeCN in 30 min).
Glycomaurrol (5): colorless crystals; mp 141 °C. UV (MeOH): λ_max = 257, 269, 292 (sh), 301, 350, 362 (sh) nm. IR (ATR): ν = 3409, 3214, 2917, 1589, 1512, 1499, 1476, 1442, 1390, 1349, 1309, 1282, 1267, 1225, 1166, 1148, 1100, 1069, 1030, 954, 871, 850, 797, 739, 694, 648 cm^-1. ¹H NMR (500 MHz, acetone-d ₆): δ = 1.72 (d, J = 1.2 Hz, 3 H), 1.98 (s, 3 H), 2.51 (s, 3 H), 4.01 (d, J = 6.5 Hz, 2 H), 5.37 (t, J = 6.5 Hz, 1 H), 7.03 (d, J = 8.5 Hz, 1 H), 7.19 (d, J = 8.5 Hz, 1 H), 7.20 (m, 1 H), 7.37 (d, J = 8.2 Hz, 1 H), 7.70 (s, 1 H), 7.95 (s, 1 H), 9.94 (br s, 1 H). ¹³C NMR and DEPT (125 MHz, acetone-d ₆): δ = 18.34 (CH₃), 21.67 (CH₃), 25.83 (CH₃), 26.24 (CH₂), 109.21 (CH), 111.09 (CH), 115.52 (CH), 122.15 (C), 122.97 (C), 123.29 (CH), 124.05 (CH), 124.34 (C), 126.87 (CH), 127.59 (C), 131.86 (C), 136.06 (C), 140.13 (C), 148.19 (C). MS (100 °C): m/z (%) = 265 (100) [M⁺], 210 (71), 209 (87), 181 (14), 180 (19), 167 (9). HRMS: m/z calcd for C₁₈H₁₉NO [M⁺]: 265.1467; found: 265.1454.

28

Crystal data for the bromocarbazole 12: C₁₄H₁₀BrNO₂, M = 304.14, monoclinic, space group: P2₁/c, a = 19.570(4), b = 8.296(2), c = 7.360(2) Å, β = 94.77(3)°, V = 1190.8(5) ų, Z = 4, D _c = 1.696 g cm^-3, µ = 3.444 mm^-1, T = 198(2) K, λ = 0.71073 Å, θ range: 3.13-30.00°, 29544 reflections collected, 3454 independent (R _int = 0.0629), 168 parameters. The structure was solved by direct methods and refined by full-matrix least-squares on F ²; final R indices [I > 2σ(I)]: R ₁ = 0.0405, wR ₂ = 0.0761; maximal residual electron density: 0.598 e Å^-3. CCDC-628163 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.

29

Pure micromeline (6) was obtained by preparative HPLC on a Vydac C8 50 mm column (gradient elution with 50 mL/min MeCN-H₂O, 30-60% MeCN in 30 min).
Micromeline (6): colorless crystals; mp 205-206 °C. UV (MeOH): λ_max = 231, 252, 276 (sh), 278, 281, 295 (sh), 300, 340 nm. IR (ATR): ν = 3156, 2963, 2911, 2854, 2740, 1663, 1649, 1629, 1603, 1566, 1522, 1464, 1446, 1371, 1310, 1291, 1271, 1228, 1202, 1181, 1164, 1120, 1063, 1028, 958, 899, 883, 851, 811, 792, 717, 663 cm^-1. ¹H NMR (500 MHz, acetone-d ₆): δ = 1.72 (d, J = 1.1 Hz, 3 H), 2.03 (s, 3 H), 4.07 (d, J = 6.4 Hz, 2 H), 5.36 (t, J = 6.4 Hz, 1 H), 7.15 (d, J = 8.5 Hz, 1 H), 7.33 (d, J = 8.5 Hz, 1 H), 7.63 (d, J = 8.5 Hz, 1 H), 7.95 (dd, J = 8.5, 1.4 Hz, 1 H), 8.03 (br s, 1 H), 8.69 (s, 1 H), 10.09 (s, 1 H), 10.70 (br s, 1 H). ¹³C NMR and DEPT (125 MHz, acetone-d ₆): δ = 18.43 (CH₃), 25.80 (CH₃), 26.19 (CH₂), 110.07 (CH), 111.79 (CH), 116.63 (CH), 122.76 (C), 123.26 (C and CH), 124.05 (C), 126.63 (CH), 127.40 (CH), 129.39 (C), 132.83 (C), 136.07 (C), 145.38 (C), 149.40 (C), 191.85 (CHO). MS (150 °C): m/z (%) = 279 (93) [M⁺], 224 (81), 223 (100), 208 (7), 195 (13), 194 (10), 183 (11), 167 (11). HRMS: m/z calcd for C₁₈H₁₇NO₂ [M⁺]: 279.1259; found: 279.1262. Anal. Calcd (%) for C₁₈H₁₇NO₂: C, 77.40; H, 6.13; N, 5.01. Found: C, 77.50; H, 6.22; N, 5.03.

30 Röhrkasten R. Konrad M. In Methoden der Organischen Chemie (Houben-Weyl)   Vol. E6b:  Kreher RP. Thieme; Stuttgart: 1994.  p.94 

31

Amberlyst 15 from Fluka (art. 06423).

32

A separation of the two isomers 7 and 15 was achieved by preparative HPLC on a Vydac C8 30 mm column (gradient elution with 40 mL/min MeCN-H₂O, 30-46% MeCN in 32 min).
Eustifoline-D (7): colorless crystals; mp 156 °C. UV (MeOH): λ_max = 253, 260 (sh), 268, 298, 310, 339, 354 nm. IR (ATR): ν = 3406, 2919, 2856, 1615, 1575, 1484, 1443, 1432, 1409, 1360, 1300, 1275, 1242, 1229, 1209, 1139, 1074, 1051, 946, 886, 875, 800, 789, 780, 750, 731, 690, 659 cm^-1. ¹H NMR (500 MHz, CDCl₃): δ = 2.59 (s, 3 H), 7.26 (dd, J = 8.3, 1.2 Hz, 1 H), 7.31 (d, J = 8.8 Hz, 1 H), 7.33 (dd, J = 2.0, 0.4 Hz, 1 H), 7.36 (d, J = 8.3 Hz, 1 H), 7.58 (d, J = 8.8 Hz, 1 H), 7.81 (d, J = 2.0 Hz, 1 H), 7.98 (s, 1 H), 8.03 (br s, 1 H). ¹³C NMR and DEPT (125 MHz, CDCl₃): δ = 21.51 (CH₃), 105.40 (CH), 107.38 (CH), 109.43 (CH), 110.43 (CH), 114.80 (C), 120.42 (C), 120.93 (CH), 123.23 (C), 126.54 (CH), 128.71 (C), 135.92 (C), 137.65 (C), 145.14 (CH), 150.27 (C). MS (20 °C): m/z (%) = 221 (100) [M⁺], 220 (53), 192 (7), 191 (8). HRMS: m/z calcd for C₁₅H₁₁NO [M⁺]: 221.0841; found: 221.0853. Anal. Calcd (%) for C₁₅H₁₁NO: C, 81.43; H, 5.01; N, 6.33. Found: C, 81.23; H, 5.07; N, 6.24.
Isoeustifoline-D (15): colorless crystals; mp 154 °C. UV (MeOH): λ_max = 247, 255, 264, 272 (sh), 304, 311 (sh), 316, 349, 365 nm. IR (ATR): ν = 3403, 2918, 2854, 1617, 1533, 1504, 1483, 1446, 1342, 1326, 1307, 1292, 1262, 1220, 1175, 1154, 1125, 1097, 1030, 978, 879, 840, 799, 790, 756, 731, 697, 619 cm^-1. ¹H NMR (500 MHz, CDCl₃): δ = 2.54 (s, 3 H), 6.83 (d, J = 2.1 Hz, 1 H), 7.24 (d, J = 8.2 Hz, 1 H), 7.28 (d, J = 8.2 Hz, 1 H), 7.47 (s, 1 H), 7.68 (d, J = 2.1 Hz, 1 H), 7.81 (br s, 1 H), 7.89 (s, 1 H), 8.10 (s, 1 H). ¹³C NMR and DEPT (125 MHz, CDCl₃): δ = 21.39 (CH₃), 100.56 (CH), 101.66 (CH), 106.53 (CH), 110.05 (CH), 120.17 (CH), 121.93 (C), 123.65 (C), 126.73 (C), 127.23 (CH), 128.34 (C), 137.38 (C), 139.00 (C), 145.65 (CH), 150.38 (C). MS (20 °C): m/z (%) = 221 (100) [M⁺], 220 (53), 192 (7), 191 (6). HRMS: m/z calcd for C₁₅H₁₁NO [M⁺]: 221.0841; found: 221.0851. Anal. Calcd (%) for C₁₅H₁₁NO: C, 81.43; H, 5.01; N, 6.33. Found: C, 80.59; H, 5.06; N, 6.15.

33 Braxmeier T, Friedrichson T, Fröhner W, Jennings G, Schlechtingen G, Schroeder C, Knölker H.-J, Simons K, Zerial M, and Kurzchalia T. inventors; PCT Int. Appl. WO  2006002908. 

34 Choi T. Czerwonka R. Fröhner W. Krahl MP. Reddy KR. Franzblau SG. Knölker H.-J. ChemMedChem  2006,  1:  812